InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 220242

Friday, 05/22/2015 11:03:55 PM

Friday, May 22, 2015 11:03:55 PM

Post# of 345784

Will help the Sr. Director of Process Sciences organize and implement the protein characterization program for both Peregrine and Avid’s clients. Utilizes a diverse array of technologies for the characterization of glycoproteins in formulations being developed at Peregrine and Avid.
...
..



this latest (partial) job description I listed above should keep everyone alert, because glycoproteins are everywhere in the body and even in the blood.

---------------

TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells.

http://www.ncbi.nlm.nih.gov/pubmed/18082433

---------------

Conclusion(s)

Our results suggest that anti-ß2GP1-ab but not aPS-ab is related to RM/UFL and should be considered as a pregnancy-loss risk factor.

http://www.fertstert.org/article/S0015-0282%2809%2900128-9/abstract

-------------

Anyone can do a simple google search and the list is endless for glycoproteins that will bind to Phosphatidylserine, so I imagine SK was true to his word regarding those "dozens of collaborations.." and logically thinking, wouldn't just one Big Pharma out there be concerned that Peregrine could easily build a very quick network, globally.

No wonder why no collaborators are coming forth, because the first few of these guys out of the gate means a lot and as much as we would like that full list of collaborators, it is exactly this long time of "no one speaks..." that will drive one Big Pharma out of the closet sooner or later.

I wouldn't want to be the one trying to pick up shares when the manipulation upward begins. Those will be the days when you place an order to buy 2 cents above and those pesky algos will be fine tuned to make you move your price up another 2-3 cents before you get filled.



Locked and ready.

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News